Immutep
IMMP
Immutep (IMMP) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Maxim Group | Upgraded | Hold → Buy | — | Jun 17, 2026 |
| Baird | Downgraded | Outperform → Neutral | $1.00 from $7.00 | Mar 13, 2026 |
| Citizens | Downgraded | Market Outperform → Market Perform | — | Mar 13, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $10.00 | Feb 23, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $6.00 | Feb 17, 2026 |
| Baird | Maintained | Outperform | $7.00 from $6.00 | Nov 15, 2024 |
| Baird | Maintained | Outperform | $6.00 from $7.00 | Jun 27, 2024 |
| Capital One | Initiated Coverage | Overweight | $10.00 | May 17, 2024 |
| Baird | Maintained | Outperform | $7.00 | Aug 28, 2023 |
| Baird | Initiated Coverage | Outperform | $7.00 | Aug 3, 2023 |
| Baird | Initiated Coverage | Outperform | $7.00 | Aug 2, 2023 |
| Maxim Group | Maintained | Buy | $10.00 from $8.00 | May 18, 2023 |
Frequently asked questions
What is the latest analyst rating on IMMP?
On Jun 17, 2026, Maxim Group upgraded Immutep to Buy.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.